A randomised study to assess the efficacy of nasojejeunal verses nasogastric enteral feeding in critically ill patients during ICU stay.

Completed

• Conditions: Critically ill patients requiring enteral feeding; Other -

• Registration Number: ACTRN12605000570684
• Lead Sponsor: Intensive Care Unit, RMH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-30
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1. Adult patients admitted to the ICU with an expected stay of more than 48h. 2. Patients commenced on enteral feeding via nasogastric route who fail to tolerate gastric feeding due to excessive gastric aspirate volumes. 3. Patients who consent or if the patient is incompetent, the next-of-kin who consent, to inclusion in the study.

Exclusion Criteria

1. Patients aged less than 18 years.2. Patients with a known allergy to promotility agents, metoclopramide or erythromycin.3. Patients with a contra-indication to nasojejunal feeding.

Study & Design

• Study Type: Interventional
• Study Design: Not specified